What is the time of action for Nitroglycerin (NTG)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nitroglycerin Time of Action

Sublingual nitroglycerin has an onset of action within 1 to 3 minutes, with maximum vasodilatory effects occurring by 5 minutes, and effects persisting for at least 25 minutes. 1

Onset and Peak Effect by Route

Sublingual Administration

  • Vasodilatory effects begin within 1 to 3 minutes after sublingual administration, with digital plethysmography demonstrating onset as early as 1 minute 1
  • Maximum effect is reached by 5 minutes postdose, corresponding with peak plasma concentrations occurring at 6 to 7 minutes 1
  • Duration of effect is 1 to 7 minutes for acute symptom relief, though hemodynamic effects persist for at least 25 minutes 2, 1
  • Anti-anginal and anti-ischemic effects begin within 2 minutes of sublingual application in exercise-induced angina 3

Intravenous Administration

  • Onset is immediate with IV administration, allowing for rapid titration 2
  • Effects are dose-dependent and continuous during infusion 4
  • Tolerance typically develops after 24 hours of continuous therapy, requiring dose adjustments 5, 4

Pharmacokinetic Profile

Absorption and Distribution

  • Absolute bioavailability of sublingual nitroglycerin is approximately 40%, though this varies due to sublingual hydration and mucosal metabolism 1
  • Peak plasma concentrations (Cmax) occur at 6 to 7 minutes after sublingual dosing 1
  • Volume of distribution is 3.3 L/kg following IV administration 1

Metabolism and Elimination

  • Elimination half-life is extremely short at 2 to 3 minutes (range 1.5 to 7.5 minutes), explaining the rapid offset of effects 1
  • Clearance (13.6 L/min) greatly exceeds hepatic blood flow, indicating extensive extrahepatic metabolism 1
  • Active metabolites (1,2- and 1,3-dinitroglycerin) have peak concentrations at approximately 15 minutes and elimination half-lives of 32 to 36 minutes, contributing to prolonged pharmacologic effects 1

Clinical Dosing Protocol

Acute Angina Management

  • Standard dose is 0.3 to 0.6 mg sublingual, most commonly 0.4 mg 6
  • May repeat every 5 minutes for up to 3 doses (total 15-minute period) 6
  • If symptoms persist after 3 sublingual doses, transition to IV nitroglycerin 2, 6

Intravenous Titration

  • Start at 10 mcg/min and increase by 10 mcg/min every 3 to 5 minutes until symptom relief or blood pressure response 2, 4
  • At doses above 20 mcg/min, may increase increments to 20 mcg/min for more aggressive titration 4
  • Common ceiling is 200 mcg/min, though doses up to 400 mcg/min have been used safely 5, 4

Important Clinical Caveats

Contraindications

  • Absolutely contraindicated within 24 hours of sildenafil or 48 hours of tadalafil use due to risk of profound hypotension, MI, and death 2, 6
  • **Avoid if systolic blood pressure <90 mmHg** or >30 mmHg below baseline 6, 5

Tolerance Development

  • Tolerance develops within 7 to 8 hours with transdermal preparations 2
  • Continuous IV infusion produces tolerance after 24 hours, requiring dose escalation or nitrate-free intervals 5, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Nitroglycerin Injection Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Nitroglycerin Dosing in Sympathetic Crashing Acute Pulmonary Edema (SCAPE)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Standard Dose of Sublingual Nitroglycerin for Acute Angina

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.